Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
10,165 total articles
Cardlytics Inc. Chief Executive Officer Amit Gupta disposed of 69,833 shares on April 6, 2026, in a transaction valued at $82,891, according to a Form 4 filing. The sale, executed to meet tax liabilities from restricted stock units that vested on April 1, 2026, leaves Gupta with 987,387 shares. The company recently reported mixed fiscal 2025 Q4 res…
Josephine Linden, a director of Lands’ End, Inc. (NASDAQ: LE), sold 3,482 shares on April 1, 2026 at $45.00 per share, for total proceeds of $156,690, according to a Form 4 filed with the Securities and Exchange Commission. The transaction was executed under a $45-per-share tender offer by LEWHP, LLC, an indirect wholly owned subsidiary of WH Topco…
Director Gordon Hartogensis sold 752 shares of Lands’ End common stock on April 1, 2026, for $45.00 per share, totaling $33,840. After the sale he directly holds 9,142 shares. The company’s shares have since fallen to $10.90, a year-to-date decline of about 21%. InvestingPro places a fair value on the stock at $14.90. Lands’ End reported fiscal 202…
Compass Diversified Holdings CFO Stephen Keller completed an indirect purchase of 30,000 shares of Compass Diversified Holdings (NYSE: CODI) on April 6, 2026, executing the transactions through retirement accounts at prices between $8.50 and $8.6619 per share for a total value of about $258,237. The trades come amid recent stock strength and as the…
Peter L. Gray, who serves as PRES LE Licensing, CAO & GC at Lands' End, Inc. (NASDAQ: LE), completed a set of equity transactions on April 1, 2026, including a sale of 11,454 shares for $515,430, option exercises and the receipt of performance-based restricted stock units. The company recently reported fourth-quarter fiscal 2025 results that missed…
Director Pauls Matthew sold 786 shares of Pelthos Therapeutics Inc. (NASDAQ:PTHS) on April 2, 2026, in two trades totaling roughly $16,439. The disposals were executed under a Rule 10b5-1 plan established December 16, 2025, to meet estimated tax obligations from the vesting of restricted stock units. The company recently reported a Q4 2025 earnings…
Richard Malamut, a director at Pelthos Therapeutics Inc (NASDAQ: PTHS), sold 590 shares on April 2, 2026, in two transactions totaling $12,340, according to a Form 4 filing. The disposals were carried out under a Rule 10b5-1 trading plan established December 16, 2025, to cover estimated taxes related to vesting restricted stock units. The company r…
Pelthos Therapeutics director Ezra M. Friedberg disposed of 558 shares of the company's common stock on April 2, 2026, under a Rule 10b5-1 plan to cover estimated tax liabilities tied to vesting restricted stock units. The combined transactions totaled $11,670. The company has reported a sharp quarterly earnings miss but showed sequential revenue g…
Michele Kim Connors, general counsel of Ambiq Micro, completed two stock sales on April 2, 2026, disposing of a total of 811 shares for $21,209 to meet tax obligations associated with previously reported restricted stock units. The trades occurred at prices between $25.55 and $26.68. Ambiq Micro's shares have climbed 20% over the last week and curr…
Kym Maas, President of LE Consumer and Chief Commercial Officer at Lands' End, sold 1,440 shares of company stock on April 1, 2026, for $64,800. On the same day Maas received shares through the exercise of restricted stock units and a performance-based retention award at no cost, and disposed of additional shares to cover tax obligations. Separatel…
Steven M. Chaouki, TransUnion's President of U.S. Markets, sold 5,000 shares on April 2, 2026, under a pre-arranged Rule 10b5-1 plan for $350,000. The share price at execution was $70.00; the stock trades near its 52-week low and is down 19% year-to-date. TransUnion has completed an acquisition adding AI-enabled telecom capabilities and set medium-…
Pelthos Therapeutics director Peter Greenleaf sold 797 shares of company stock on April 2, 2026, under a pre-arranged 10b5-1 plan for $16,669. The company posted a fourth-quarter 2025 EPS well below expectations, though quarterly revenue and 2025 net product revenue climbed on the back of a mid-year product launch. Analyst coverage was unchanged in…
Director Barry M Smith disposed of 700 shares of The Ensign Group on April 2, 2026, under a Rule 10b5-1 plan, netting $137,655. The transaction occurred as the stock traded near $198, up 52% year-over-year; some analysis flags the equity as potentially overvalued with a P/E of 33.84. Separately, Ensign reported Q4 2025 adjusted EPS of $1.82, beatin…
Andrew Dakos, President and CEO of Total Return Securities Fund (NYSE:SWZ), bought a total of 4,963 shares across two transactions in early April for a combined reported outlay of $29,422. After these purchases Dakos holds 39,453 shares directly and 88,282 shares indirectly via a limited partnership. The fund currently trades close to its 52-week l…
TD Synnex Chief Financial Officer David Gregory Jordan sold 3,225 shares of common stock on April 6, 2026, for $189.46 per share, generating proceeds of $611,008. The transaction occurred while the stock traded close to its 52-week peak of $191.78 after a nearly 98% gain over the prior 12 months. Management buybacks and robust fiscal first-quarter …
Melanie Carpenter, executive vice president and chief human resources officer of Mid America Apartment Communities Inc (MAA), executed multiple transactions in early April 2026 that included a sale of 731 shares for roughly $91,214 and other dispositions and acquisitions recorded on a Form 4 filing. The company also announced a quarterly dividend a…
United Therapeutics Corp CFO and Treasurer Edgemond James sold 7,762 shares on April 2, 2026, realizing roughly $5.6 million, and exercised options for 10,000 shares at $135.42 for $1,354,199. The trades were made under a Rule 10b5-1 plan. The company's shares have risen 93% over the past year and trade at $559.65, while multiple analysts raised pr…
United Therapeutics Chairperson and CEO Martine Rothblatt sold about $5.3 million of company stock on April 2, 2026, and exercised options to acquire additional shares. The transactions were disclosed on a Form 4 and executed under a 10b5-1 plan adopted in November 2025. The company has recently drawn analyst attention after positive Phase 3 TETON-…
Timothy Argo, Executive Vice President, Chief Strategy & Analysis at Mid-America Apartment Communities Inc (NYSE: MAA), reported sales and other equity transactions in early April 2026. The REIT also announced its quarterly dividend and has seen a mix of analyst price-target changes and ratings reflecting differing perspectives on rental-market dyn…
Jennifer Ladd Hanson, Chief People Officer of CarGurus, sold 567 shares of Class A common stock on April 2, 2026, for $33.04 per share, totaling $18,733. The transaction was carried out under a Rule 10b5-1 plan and the Form 4 was signed by Suzanne Murray as attorney-in-fact on April 6, 2026. After the sale Hanson holds 96,432 shares. The stock trad…
Carlos E. Evans, a director at Goldman Sachs BDC, acquired 50,000 shares of the company's common stock on April 2, 2026, investing $451,035 at a weighted average price of $9.0207. The purchase increases his direct holding to 64,446 shares. Goldman Sachs BDC reported a fourth-quarter 2025 EPS beat but slightly missed revenue expectations and recentl…
John Uczekaj, President and COO of AIRO Group Holdings, reported a sale of 3,415 shares on April 6, 2026, to satisfy tax withholding related to restricted stock unit vesting. The $30,176 transaction was executed at a weighted average price of $8.8364. The move comes as AIRO stock trades below its annual level and after the company reported Q4 2025 …
Amber Fairbanks, EVP of Property Management at Mid-America Apartment Communities (MAA), sold 711 shares on April 6, 2026, for about $88,683 under a 10b5-1 plan. The move follows an April 1 purchase and a tax-related disposal, and arrives as analysts trim price targets while the REIT offers a 4.9% yield and is viewed as overvalued by InvestingPro.
Dafna Sarnoff, Chief Marketing Officer of CarGurus, sold 5,445 shares of Class A common stock on April 2, 2026, for $33.04 per share, generating $179,902. After the trade she holds 134,369 shares. The transaction was completed under a Rule 10b5-1 trading plan. Separately, CarGurus reported 15% year-over-year total revenue growth for the fourth quar…
CarGurus Chief Technology Officer Matthew Todd Quinn sold 4,341 shares of Class A common stock on April 2, 2026, at $33.04 per share, realizing $143,426. The sale, executed under a Rule 10b5-1 trading plan, leaves Quinn with 246,098 shares. CarGurus shares trade at $34.75, the stock is up 27% over the last year but down 13% year-to-date, and the co…
